The Cure(ious)TM
February 19, 2025
Munjal Shah, Co-Founder and CEO of Hippocratic AI, was recently featured in “The Cure(ious)” series by the New York Stock Exchange (NYSE). This series invites
A generative artificial intelligence startup focused on building foundation models for health care and using it to improve patient outcomes, lower health care costs, and address the growing shortage of health care workers worldwide.
Founded by generative AI researchers, hospital administrators, physicians, and Medicare experts, Hippocratic AI has developed a safety-focused large language model to provide nondiagnostic health care services. Its large language model outperformed Open AI’s GPT-4 on 105 of 114 health care exams and certifications. Hippocratic AI has received a total of $120M in funding and is backed by leading investors, including General Catalyst, Andreessen Horowitz, Premji Invest, and SV Angel.
Munjal Shah, Co-Founder and CEO of Hippocratic AI, was recently featured in “The Cure(ious)” series by the New York Stock Exchange (NYSE). This series invites
I was recently a guest speaker at CES, where we delved into a range of compelling topics. The discussion highlighted the critical role of empathy
Hippocratic AI announced the launch of Polaris 5.0, the newest version of its healthcare-focused AI platform designed for voice-based patient interactions. The company said Polaris 5.0 was built using more than 180 million real patient interactions and validated by over 7,500 U.S.-licensed clinicians. Hippocratic AI claims the model outperformed major frontier AI models from OpenAI, […]
Hippocratic AI announced five new senior leadership appointments to expand its life sciences business as it continues growing its generative AI platform for pharma, biotech, and medtech organizations. The hires follow the company’s acquisition of Grove AI in early 2026 and the launch of Polaris Life Sciences 5.0, reinforcing Hippocratic AI’s effort to position its […]
Hippocratic AI announced several new senior executive appointments to expand its life sciences leadership team as demand grows for its voice and conversational AI agents